España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Monte Rosa Therapeutics
GLUE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$4.68
-0.19
-3.90%
Last update: 10:22 AM
15 minutes delayed
Get Report
Comment
Monte Rosa Therapeutics (GLUE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Monte Rosa Therapeutics (NASDAQ:GLUE) Stock
Monte Rosa Therapeutics Stock (NASDAQ: GLUE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, July 01, 2024
Watching Monte Rosa Therapeutics, Zura Bio; S...
Benzinga Newsdesk
Friday, June 28, 2024
Piper Sandler Reiterates Overweight on Monte ...
Benzinga Newsdesk
Thursday, June 27, 2024
Monte Rosa Therapeutics Announced Progress Up...
Benzinga Newsdesk
Friday, June 14, 2024
Monte Rosa Therapeutics Presents Preclinical ...
Benzinga Newsdesk
Wednesday, May 22, 2024
Wedbush Reiterates Outperform on Monte Rosa T...
Benzinga Newsdesk
Tuesday, May 21, 2024
Monte Rosa Therapeutics Will Present Preclini...
Benzinga Newsdesk
Thursday, May 16, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Monte Rosa Therapeutics shares are trading lo...
Benzinga Newsdesk
Monte Rosa Therapeutics Reports Pricing Of $1...
Benzinga Newsdesk
Wednesday, May 15, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Monte Rosa Therapeutics Announces Proposed Pu...
Benzinga Newsdesk
Thursday, May 09, 2024
Monte Rosa Therapeutics Expects Its Cash And ...
Benzinga Newsdesk
Monte Rosa Therapeutics Q1 2024 GAAP EPS $(0....
Benzinga Newsdesk
Tuesday, March 26, 2024
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Thursday, March 14, 2024
Monte Rosa Therapeutics: Q4 Earnings Insights
Benzinga Insights
Monte Rosa Therapeutics Q4 EPS $(0.58) Misses...
Benzinga Newsdesk
Monday, March 11, 2024
Monte Rosa Therapeutics Announced MRT-8102 Is...
Benzinga Newsdesk
Friday, February 16, 2024
CORRECTION: Wedbush initiated coverage on Mon...
Benzinga Newsdesk
Thursday, February 15, 2024
Monte Rosa Therapeutics' AI And Machine Learning Platform Is Adding Significant Value Creation in Cancer Research: Analyst
Vandana Singh
Wedbush Initiates Coverage On Monte Rosa Ther...
Benzinga Newsdesk
Wednesday, January 10, 2024
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
Avi Kapoor
Monday, January 08, 2024
Monte Rosa Therapeutics Announced Cash Position Expected To Fund Operations Into H1 2026
Charles Gross
Thursday, December 14, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Wednesday, December 13, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Thursday, November 09, 2023
Monte Rosa Therapeutics: Q3 Earnings Insights
Benzinga Insights
Monte Rosa Therapeutics Q3 EPS $(0.70) Beats ...
Benzinga Newsdesk
Tuesday, November 07, 2023
Monte Rosa Therapeutics Presents Preclinical ...
Benzinga Newsdesk
Thursday, October 19, 2023
JP Morgan Maintains Overweight on Monte Rosa ...
Benzinga Newsdesk
Tuesday, October 17, 2023
Crude Oil Moves Lower; Bank of America Profit Beats Expectations
Lisa Levin
Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Dow Surges 100 Points; Goldman Sachs Posts Upbeat Earnings
Lisa Levin
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
Vandana Singh
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monte Rosa Therapeutics Announced Interim Dat...
Benzinga Newsdesk
Monte Rosa Therapeutics Announces Collaborati...
Benzinga Newsdesk
Monday, October 02, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, August 11, 2023
Credit Suisse Reiterates Neutral on Monte Ros...
Benzinga Newsdesk
Thursday, July 27, 2023
Director at Monte Rosa Therapeutics Acquires Company Stock Options Worth 41,000 Shares
Benzinga Insights
Tuesday, May 23, 2023
Monte Rosa Therapeutics Advances Second Devel...
Benzinga Newsdesk
Friday, May 12, 2023
Credit Suisse Reiterates Neutral on Monte Ros...
Benzinga Newsdesk
Thursday, May 11, 2023
Monte Rosa Therapeutics Q1 EPS $(0.65) Down F...
Benzinga Newsdesk
Wednesday, April 26, 2023
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, April 25, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, April 24, 2023
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Monday, April 17, 2023
Monte Rosa Therapeutics Presents Preclinical ...
Michael Horton
Friday, March 17, 2023
Credit Suisse Maintains Neutral on Monte Rosa...
Benzinga Newsdesk
Friday, March 10, 2023
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Monday, January 09, 2023
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch